Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Vaccine. 2013 Aug 12;31(42):4795–4801. doi: 10.1016/j.vaccine.2013.07.085

Fig. 2.

Fig. 2

Expression of lambda chain or lambda-NAP transgene by MV-lambda or MV-lambda-NAP infected cells. Vero cells were inoculated at MOI = 1.0 with ether MV-lambda or MV-lambda-NAP. Concentration of human lambda antigen in the supernatants was measured at 24, 48 and 72 h and transgene expression per 106 infected cells was calculated.